Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Madrigal May Shake Up NASH Race With Phase II Resolution Data

scientists doing lab research on digital screen

Related Content

Genfit May Be Gaining An Edge In NASH Race

Oct 26 2017

Intercept's Revised NASH Trial Improves Prospects

Feb 13 2017

Madrigal's Early Phase IIb NASH Data Show Clinically Meaningful Fat Reduction

Dec 06 2017

Combination Strategies A Common Thread In NASH R&D

Nov 21 2016

Related Companies

Madrigal Pharmaceuticals, Inc.

Roche Holding AG

Intercept Pharmaceuticals, Inc.

Allergan plc

Genfit SA

Gilead Sciences, Inc.

Additional Topics

Research & Development Clinical Trials Liver & Hepatic BioPharmaceutical Metabolic Disorders

More from R&D

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window